Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Tables)

v3.19.3
Stockholders' Equity (Tables)
9 Months Ended
Sep. 30, 2019
Stockholders' Equity Note [Abstract]  
Schedule of stock-based compensation
    For the Three Months Ended
September 30,
    For Nine Months Ended
September 30,
 
    2019     2018     2019     2018  
Research and development   $ 201,259     $ 1,188,545     $ 711,401     $ 2,299,934  
General and administrative     383,251       424,809       1,300,932       1,100,598  
Total   $ 584,510     $ 1,613,354     $ 2,012,333     $ 3,400,532  
Schedule of stock option activity
              Weighted Average        
    Stock Options     Exercise Price     Fair Value     Contractual     Aggregate  
    Outstanding     Exercisable     Outstanding     Exercisable     Vested     Life (Years)     Intrinsic Value  
Balance – December 31, 2018     5,488,282       4,384,294     $ 2.10     $ 1.32     $ 1.32       5.80     $ -  
Granted     2,579,000       -       -       -       -       -       -  
Exercised     (233,214 )     -       -       -       -       -       -  
Cancelled     (177,672 )     -       -       -       -       -       -  
Balance – September 30, 2019     7,656,396       4,646,317     $ 2.14     $ 1.50     $ 1.50       6.27     $ 833,793  
Schedule of stock options outstanding and exercisable
Grant Price     Weighted Average Exercise     Total     Number     Weighted Average
From     To     Price     Outstanding     Exercisable     Remaining Contractual Term
$ 0.26     $ 2.02     $ 0.89       3,298,353       3,282,936     3.81 years
$ 2.10     $ 4.60     $ 2.47       3,665,043       936,167     8.89 years
$ 5.30     $ 8.86     $ 6.62       693,000       427,214     8.61 years
                  Totals       7,656,396       4,646,317  
Schedule of warrants activity
              Weighted Average        
    Warrants     Exercise Price     Fair Value     Contractual     Aggregate  
    Outstanding     Exercisable     Outstanding     Exercisable     Vested     Life (Years)     Intrinsic Value  
Balance – December 31, 2018     4,964,205       4,907,223     $ 2.39     $ 2.39     $ 1.14       2.27     $ -  
Granted     -       -       -       -       -       -       -  
Exercised     (50,000 )     -       -       -       -       -       -  
Cancelled     (6,982 )     -       -       -       -       -       -  
Balance – September 30, 2019     4,907,223       4,907,223     $ 2.40     $ 2.40     $ 1.11       1.55     $ 1,175,115